IDEXX Laboratories, Inc. (IDXX), a leading provider of pet healthcare services, announced its financial outlook for the 2025 fiscal year while presenting its fourth-quarter results on Monday. The company's projections align with the consensus expectations of market analysts.
For the full year of 2025, IDEXX anticipates earnings per share to range from $11.74 to $12.24, with expected revenue between $4.055 billion and $4.170 billion. This forecast represents a revenue growth of 4 to 7 percent, with organic revenue growth estimated between 6 to 9 percent.
Market analysts, as surveyed by Thomson Reuters, predict IDEXX will achieve earnings of $11.84 per share on revenue totaling $4.15 billion over the same period. It's worth noting that these analyst predictions generally do not account for special items.
